Advanced BioMedical Technologies's accounts payable is $890K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Advanced BioMedical Technologies (ABMT) currently reports a accounts payable of $890K as of July 2022. That compares with $1.2M in the prior-year period — down 23.6% year over year. Use the charts on this page to explore Advanced BioMedical Technologies's accounts payable history and peer comparisons.
Advanced BioMedical Technologies's accounts payable decreased from $1.2M to $890K — a 23.6% year-over-year decrease (period ending July 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Advanced BioMedical Technologies reported $890K in accounts payable as of July 2022. That compares with $1.2M in the prior-year period — down 23.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current accounts payable of $890K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Advanced BioMedical Technologies, and consider following ABMT for alerts when major investors trade the stock.